Gold used as safe driver of cancer drug

Mar 21, 2012
The cancer drug cisplatin could be significanly improved by gold nanoparticles, says Dr. Nial Wheate.

(PhysOrg.com) -- Gold nanoparticles can be used as delivery vehicles for platinum anticancer drugs, improving targeting and uptake into cells, according to research published in this month's edition of the international journal Inorganic Chemistry.

Researchers at the University of Sydney's Faculty of Pharmacy investigated the appropriateness of different sized as components of platinum-based such as cisplatin.

The researchers studied the cancer drug's controlled synthesis, reproducibility, consistency of drug loading and stability.

According to Dr. Nial Wheate, senior lecturer in and leader of the project, the effectiveness of the cancer could be significantly improved by gold nanoparticles, which selectively pick up and drive the platinum-based drug into solid .

Dr. Wheate says the team conducted multiple testing regimes on the gold nanoparticles:

"For any new drug to get approval for human clinical trials, it must demonstrate not only efficiency but also the capability of being reproducibly manufactured and stable in storage," he says.

"Developing and making a drug is a lot like building and designing a car. You have to test and retest it for durability and all the safety features.

"Previously, we have shown that platinum drugs can be attached to gold nanoparticles and that cellular uptake and effectiveness levels are greatly improved.

"But we needed to be sure that the benefits of the drug would be consistent. We believed when developing gold nanoparticles as platinum drug-delivery vehicles, it was essential they were reproducible and stable to ensure consistent and safe doses were administered to patients."

Cisplatin is the leading metallodrug used in the systemic treatment of solid tumors.

"To date, however, its use has been limited by severe , attributed to the indiscriminate accumulation of the drug in both normal and cancerous tissue," says Dr. Wheate.

Cisplatin is currently used to treat several types of cancers including testicular, ovarian, bladder, oesophageal, lung, and cervical cancers and melanomas.

Explore further: 'Stealth' nanoparticles could improve cancer vaccines

Provided by University of Sydney

5 /5 (2 votes)

Related Stories

Gold Nanoparticles Delivery Platinum Warheads to Tumors

Oct 29, 2009

(PhysOrg.com) -- Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but serious side effects ultimately limit the drug's use and effectiveness. Now, however, researchers have ...

Super-sizing a cancer drug minimizes side effects

Jul 28, 2010

One of the first chemotherapy drugs given to patients diagnosed with cancer — especially lung, ovarian or breast cancer — is cisplatin, a platinum-containing compound that gums up tumor cells’ DNA. Cisplatin ...

Gold nanoparticles for controlled drug delivery

Dec 30, 2008

(PhysOrg.com) -- Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion.

Platinum and light together fight cancer

Sep 14, 2010

(PhysOrg.com) -- Researchers continue to search for cancer treatments that effectively destroy tumor cells while protecting surrounding healthy tissue and the body. One intriguing approach involves photoactivated ...

Metals could forge new cancer drug

Oct 19, 2009

Drugs made using unusual metals could form an effective treatment against colon and ovarian cancer, including cancerous cells that have developed immunity to other drugs, according to research at the University ...

Recommended for you

'Stealth' nanoparticles could improve cancer vaccines

10 hours ago

Cancer vaccines have recently emerged as a promising approach for killing tumor cells before they spread. But so far, most clinical candidates haven't worked that well. Now, scientists have developed a new ...

Nanoparticles accumulate quickly in wetland sediment

10 hours ago

(Phys.org) —A Duke University team has found that nanoparticles called single-walled carbon nanotubes accumulate quickly in the bottom sediments of an experimental wetland setting, an action they say could ...

User comments : 0